
|Articles|February 1, 2005
Advances provide sustained drug release for retinal disease
Baltimore—Innovative pharmaceutical delivery systems are showing promise for their potential to provide safe and effective "site-directed" therapy for retinal diseases, said Eugene de Juan Jr., MD, in the Ronald G. Michels Memorial Lecture at the Current Concepts of Ophthalmology meeting.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
RCA releases first State of Retina Care report
2
OT Roundup ep. 1: ADHD's eye link, MOGENRY's BLA, and myopia news
3
Eichenbaum Acorns: A passion for retina science with Andrea Gibson, PhD, and Erin C. Henry, PhD
4
FAQ: What retina specialists need to know about the MOGENRY (MCO-010) BLA acceptance
5











